Journal of Clinical Epidemiology
Volume 54, Issue 1 , Pages 1-22 , January 2001

Multiple sclerosis in the Faroe Islands: an epitome

  • John F. Kurtzke

      Affiliations

    • Neuroepidemiology Section, Veterans Affairs Medical Center, 50 Irving Street, NW, Washington, DC 20422, and Department of Neurology, Georgetown University School of Medicine, Washington, DC USA
    • Corresponding Author InformationCorresponding author. Tel.: (703)560-6016; fax: (703)560-6490
    • ,
  • Anne Heltberg

      Affiliations

    • Department of Neurology, Roskilde Hospital, Roskilde, Denmark

Received 11 November 1999 ,Revised 29 March 2000 ,Accepted 20 April 2000.

References 

  1. Kurtzke JF. The epidemiology of multiple sclerosis. In:  Raine CS,  McFarland H,  Tourtellotte WW editor. Multiple sclerosis (clinical and pathogenetic basis). London: Chapman & Hall; 1997;p. 91–139
  2. Kurtzke JF, Wallin MT. Epidemiology. In: Burks JS, Johnson KB, editors. Multiple sclerosis: diagnosis, medical management, and rehabilitation. New York: Demos Press, in press.
  3. Paul JR. Clinical epidemiology, revised ed. Chicago: University of Chicago, 1966. p. 60
  4. Kurtzke JF, Hyllested K. Multiple sclerosis. An epidemic disease in the Faeroes. Trans Am Neurol Assoc. 1975;100:213–215
  5. Kurtzke JF, Hyllested K. Multiple sclerosis in the Faroe Islands. 1. Clinical and epidemiological features. Ann Neurol. 1979;5:6–21
  6. Kurtzke JF, Hyllested K. Multiple sclerosis in the Faroe Islands (II. Clinical update, transmission, and the nature of MS). Neurology. 1986;36:307–328
  7. Kurtzke JF, Hyllested K. Multiple sclerosis in the Faroe Islands (III. An alternative assessment of the three epidemics). Acta Neurol Scand. 1987;76:317–339
  8. Kurtzke JF, Hyllested K, Heltberg A, Olsen Á. Multiple sclerosis in the Faroe Islands. 5. The occurrence of the fourth epidemic as validation of transmission. Acta Neurol Scand. 1993;88:161–173
  9. Rutherford GK, Taylor CEB. The physical environment of the Faroe Islands. Location and general description. The Hague: Dr. W. Junk Publisher; 1982;p. 3–12.
  10. Young GVC. From the Vikings to the Reformation. A chronicle of the Faroe Islands up to 1538. Douglas, Isle of Man: Shearwater Press, 1979.
  11. Schumacher GA, Beebe GW, Kibler RF, et al.  Problems of experimental trials of therapy in multiple sclerosis (report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis). Ann New York Acad Sci. 1965;122:552–568
  12. Poser CM, Paty DW, Scheinberg L, et al.  New diagnostic criteria for multiple sclerosis (guidelines for research protocols). Ann Neurol. 1983;13:227–231
  13. Kurtzke JF, Hyllested K. Validity of the epidemics of multiple sclerosis in the Faroe Islands. Neuroepidemiology. 1988;7:190–227
  14. Kurtzke JF, Hyllested K, Heltberg A. Multiple sclerosis in the Faroe Islands. In:  Molgaard CA editors. Neuroepidemiology (theory and method). San Diego: Academic Press; 1993;p. 23–51
  15. Kurtzke JF, Wallin MT. Survival analysis in neurological disease. In: Hofman A, Mayeux R, editors. Epidemiology for clinical neurology. Oxford, England: Oxford University Press, in press.
  16. Kurtzke JF, Hyllested K, Heltberg A. Multiple sclerosis in the Faroes (transmission across four epidemics). Acta Neurol Scand. 1995;91:321–325

☆ Dedicated to our good friend and colleague, the late Kay Hyllested.

PII: S0895-4356(00)00268-7

Journal of Clinical Epidemiology
Volume 54, Issue 1 , Pages 1-22 , January 2001

Article Tools

* Image Usage & Resolution